Cr-001
Locally Advanced / Metastatic Solid Tumors
Phase I/II
Not Yet Recruiting
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Jan 08, 2026
―
Rivipansel
Anemia, Sickle Cell
Phase III
Completed
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Jun 12, 2014
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Crescent Biopharma (C68) have in its pipeline
C68 is currently developing the following drugs: Cr-001, Rivipansel. These drug candidates are in various stages of clinical development as the company works toward FDA approval.